Resources
AVAC’s Resource Database contains educational and advocacy materials covering a wide range of issues on biomedical prevention of HIV, STIs, COVID-19 and emerging health threats—from research to rollout.
To search for clinical trials and detailed information on products in development, visit our Prevention Research & Development Database
Results
showing 1-10 of 22
Px Wire September 2023
PrEP Tracker data, preparing for new products, the HIV prevention pipeline and our prevention playlist. All that and more in the latest issue of PxWire.
Global Investment in HIV Cure Research & Development in 2021
The 2021 report of Cure Resource Tracking Group, a collaboration between AVAC and the International AIDS Society, showed a remarkable 30 percent increase in funding for cure research. The report also provides an analysis of the cure research agenda and the scientific questions shaping investment decisions.
Prevention Option:
Advancing HIV Cure to Africa: What is needed?
This webinar discussed how researchers, communities and other stakeholders from high income countries could work equitably with low- and middle-income countries in the interests of an HIV cure for all.
Prevention Option:
Language for HIV Cure
This document shares up-to-date, community-preferred terminology within cure research.
Prevention Option:
Breaking Down the Latest in HIV Cure Research: What do new data mean for people living with HIV
In this AVAC-hosted webinar, researchers broke down the recent case of HIV cure, the first among women.
Prevention Option:
CUREiculum 2.0
The CUREiculum strengthens community capacity to understand and engage in discussions about HIV cure-related research by providing basic information on a variety of topics in meaningful and accessible language.
Prevention Option:
Global Investment in HIV Cure Research and Development in 2020
In 2014, the HIV Vaccines and Microbicides Resource Tracking Working Group and AVAC began a collaboration with the International AIDS Society’s Towards an HIV Cure initiative. AVAC, Treatment Action Group and the IAS brought together a group to review and allocate grants towards HIV cure research and analyze data on global funding.
Prevention Option:
The Case For an HIV Cure and How to Get There
Appearing in The Lancet HIV: We propose steps to plan for an HIV cure now, including defining a target product profile and establishing the HIV Cure Africa Acceleration Partnership (HCAAP), a multidisciplinary public-private partnership that will catalyse and promote HIV cure research through diverse stakeholder engagement. HCAAP will convene stakeholders, including people living with HIV, at an early stage to accelerate the design, social acceptability, and rapid adoption of HIV-cure products.
Prevention Option:
AVAC’s “3D” View of the World: 2019 and beyond
This infographic lays out AVAC’s top-line recommendations from AVAC Report 2019: Now What? The recommendations fall into three categories: deliver — prevention programs whose impact is well-measured and -defined; demonstrate — next-generation...
Prevention Option:
Global Investment in HIV Cure Research and Development in 2018
In 2014, the HIV Vaccines and Microbicides Resource Tracking Working Group and AVAC began a collaboration with the International AIDS Society’s (IAS) Towards an HIV Cure initiative. AVAC, Treatment Action Group (TAG) and the IAS brought together a...
Prevention Option:
showing 1-10 of 22